Funder: Vertex Pharmaceuticals
Due Dates: Rolling (most grants, ISS for CF, Pain, IgAN, education, advocacy, sponsorships) | 2026 (next cycle for Circle of Care, RIA, and VIA awards)
Funding Amounts: No strict cap for most grants; typical awards: up to $750,000 over 3 years (CF Independent RIA, VIA), up to $125,000 over 2 years (CF Mentored RIA); sponsorships/grants sized to fair market value and may not exceed 30% of an organization’s annual budget
Summary: Supports independent research, education, and sponsorships advancing care and knowledge for cystic fibrosis and other Vertex focus diseases.
Key Information: Rolling submission for most programs; RFP/cycles for some disease areas; strict alignment with Vertex's research interests required.